Dr. Meg Mooney helps coordinate cancer clinical trial networks across the country and internationally, and also organizes initiatives related to innovative cancer treatment reviews and precision medicine. In this episode, Mooney discusses a new natural history study the National Cancer Institute launched for cancer patients with COVID-19, as well as the work being done in drug discovery and development during this time.
HealthCast
Season 1
Episode 10
18m listen
Dr. Meg Mooney, Associate Director of CTEP, NCI
Share
The office coordinates nationwide testing of new treatment approaches for cancer.
-
Meg Mooney Associate Director of CTEP NCI
Related Content
-
Navy Pushes AI from Experiments to Everyday Warfighting Functions
The Navy’s hybrid fleet hinges on a common naval lexicon and trustworthy AI woven into every intelligence function.
6m watch -
Why Federal Experience Matters After Leaving Government
Jose Arrieta, former HHS CIO, discusses how federal civil servants can carry their high-stakes experience and resilience into careers beyond public service.
7m watch -
How the Marine Corps Is Building a High-Tech Future Fleet
The Marine Corps is leveraging AI to automate tedious tasks, enhance data readiness and accelerate mission-critical functions.
8m watch -
New NPS Challenge Aims to Rewrite How the Military Builds Missiles
Officials say focusing on design methods, not hardware, could unlock fast, low‑cost manufacturing for future munitions.
11m watch
